Asia-pacific Synthetic Biology Market was worth USD 1.17 billion in 2018 and is projected to grow at a CAGR of 26.8%, to reach USD 3.83 billion by 2023. Synthetic biology is a branch of science combining biology and engineering. It brings together several disciplines from both these fields such as genetic engineering, biotechnology, molecular engineering, computer engineering and evolutionary biology. In synthetic biology, these disciplines are applied to build artificial biological systems to be used in engineering, research and medical applications.
To achieve the intended biological system through DNA modification or sequencing, technology plays a major role. Computer aided designs are needed to model the designs accurately and technologies which can read and write DNA are highly useful. By combining advances in biology with the modern technologies, organisms can be designed to produce several chemicals or enzymes or biofuels.
Increasing expenditure on research and development of biotechnology and pharmaceutical companies, increasing demand for genetically modified crops and major technological advancements in DNA studies are the major factors driving the market growth. Increasing demand for alternate fuels such as biofuels and growing popularity for protein therapeutics are also expected to propel the market growth. However, ethical concerns regarding the biosafety and biosecurity and stringent regulations are hindering the growth of the market.
The Synthetic Biology market is categorized by tool, technology, application and region. Based on tools, the market is categorized into Chassis Organisms, Cloning and Assembly kits, Oligonucleotide Synthesis, Enzymes and XNA. Xeno nucleic acid is the largest market segment due to the high demand for synthetic alternatives to nucleic acids DNA and RNA. On the basis of technology, the market is categorized into Enabling technologies and Enabled Technologies. Enabled technologies are expected to be the largest market segment and enabling technologies are the fastest growing market segment due to several ongoing researches which might result in innovative technologies or ideas for application of synthetic biology. Enabling technologies are again categorized into Gene Synthesis, Cloning and Sequencing, Genome Engineering, Bioinformatics, Nanotechnology, Site-Directed Mutagenesis, Microfluidics and Measurement and Modeling. Gene synthesis is the major market segment in enabling technologies due to the increasing demand for protein synthesis through synthetic means. Enabled technologies are further categorized into Next-Generation Sequencing and Pathway Engineering. Based on application, the market is categorized into Medical, Environmental and Industrial fields. Industrial applications segment is the largest market segment whereas application of synthetic biology in medicine is rapidly gaining popularity.
On the basis of region, the Asia-pacific Synthetic Biology market is categorized into China, India, Japan, Australia and South Korea. Asia Pacific is the fastest growing market segment due to the growing awareness and increasing collaborations with western companies in China and also due to the well-established biotechnology industries in Japan.
Some of the major players in Synthetic Biology market are Dupont, Intrexon Corporation, Amyris, Inc., Genscript USA, Inc., Integrated Dna Technologies (IDT), Inc., Novozymes, Royal DSM N.V, New England Biolabs, Inc., Synthetic Genomics, Inc. and Thermo Fisher Scientific, Inc.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Tools
5.1.1 Introduction
5.1.2 Chassis Organisms
5.1.3 Cloning and Assembly kits
5.1.4 Oligonucleotide Synthesis
5.1.5 Enzymes
5.1.6 Xeno Nucleic Acid
5.1.7 Y-o-Y Growth Analysis, By Tool
5.1.8 Market Attractiveness Analysis, By Tool
5.1.9 Market Share Analysis, By Tool
5.2 Technology
5.2.1 Introduction
5.2.2 Enabling technologies
5.2.2.1 Gene Synthesis
5.2.2.2 Cloning and Sequencing
5.2.2.3 Genome Engineering
5.2.2.4 Bioinformatics
5.2.2.5 Nanotechnology
5.2.2.6 Site-Directed Mutagenesis
5.2.2.7 Microfluidics
5.2.2.8 Measurement and Modeling
5.2.3 Enabled technologies
5.2.3.1 Next-Generation Sequencing
5.2.3.2 Pathway Engineering
5.2.4 Y-o-Y Growth Analysis, By Technology
5.2.5 Market Attractiveness Analysis, By Technology
5.2.6 Market Share Analysis, By Technology
5.3 Application
5.3.1 Introduction
5.3.2 Medical Applications
5.3.3 Environmental Applications
5.3.4 Industrial Applications
5.3.5 Y-o-Y Growth Analysis, By Application
5.3.6 Market Attractiveness Analysis, By Application
5.3.7 Market Share Analysis, By Application
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Tool
6.1.3.3 By Technology
6.1.3.4 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Tool
6.1.4.3 By Technology
6.1.4.4 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Tool
6.1.5.3 By Technology
6.1.5.4 By Application
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Dupont
8.1.1 Overview
8.1.2 Tool Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Intrexon Corporation
8.3 Amyris, Inc.
8.4 Genscript USA, Inc.
8.5 Integrated Dna Technologies
8.6 Novozymes
8.7 Royal DSM N.V
8.8 New England Biolabs
8.9 Synthetic Genomics
8.10 Thermo Fisher Scientific
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
